NZ600243A - Combination of theobromine with a decongestant and its use for the treatment of cough - Google Patents
Combination of theobromine with a decongestant and its use for the treatment of coughInfo
- Publication number
- NZ600243A NZ600243A NZ600243A NZ60024310A NZ600243A NZ 600243 A NZ600243 A NZ 600243A NZ 600243 A NZ600243 A NZ 600243A NZ 60024310 A NZ60024310 A NZ 60024310A NZ 600243 A NZ600243 A NZ 600243A
- Authority
- NZ
- New Zealand
- Prior art keywords
- decongestant
- theobromine
- cough
- treatment
- combination
- Prior art date
Links
- 239000000850 decongestant Substances 0.000 title abstract 4
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 title abstract 4
- 206010011224 Cough Diseases 0.000 title abstract 2
- 229960004559 theobromine Drugs 0.000 title abstract 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical group CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 abstract 2
- 229960003908 pseudoephedrine Drugs 0.000 abstract 2
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 abstract 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 abstract 2
- BYJAVTDNIXVSPW-UHFFFAOYSA-N tetryzoline Chemical compound N1CCN=C1C1C2=CC=CC=C2CCC1 BYJAVTDNIXVSPW-UHFFFAOYSA-N 0.000 abstract 2
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- MYWUZJCMWCOHBA-SECBINFHSA-N levmetamfetamine Chemical compound CN[C@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-SECBINFHSA-N 0.000 abstract 1
- 229950007554 levmetamfetamine Drugs 0.000 abstract 1
- 229960005016 naphazoline Drugs 0.000 abstract 1
- 229960003684 oxedrine Drugs 0.000 abstract 1
- 229960001528 oxymetazoline Drugs 0.000 abstract 1
- 229960001802 phenylephrine Drugs 0.000 abstract 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
- 229960000395 phenylpropanolamine Drugs 0.000 abstract 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 abstract 1
- 229960000786 propylhexedrine Drugs 0.000 abstract 1
- JCRIVQIOJSSCQD-UHFFFAOYSA-N propylhexedrine Chemical compound CNC(C)CC1CCCCC1 JCRIVQIOJSSCQD-UHFFFAOYSA-N 0.000 abstract 1
- 229960000337 tetryzoline Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0921805.8A GB0921805D0 (en) | 2009-12-14 | 2009-12-14 | Drug composition and its use in therapy |
| PCT/GB2010/052085 WO2011073646A1 (en) | 2009-12-14 | 2010-12-14 | Combination of theobromine with a decongestant and its use for the treatment of cough |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ600243A true NZ600243A (en) | 2013-07-26 |
Family
ID=41667045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ600243A NZ600243A (en) | 2009-12-14 | 2010-12-14 | Combination of theobromine with a decongestant and its use for the treatment of cough |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP2512464A1 (enExample) |
| JP (2) | JP2013513651A (enExample) |
| CN (2) | CN102740843A (enExample) |
| AU (1) | AU2010332494B2 (enExample) |
| BR (1) | BR112012014161A2 (enExample) |
| CA (1) | CA2784214C (enExample) |
| CO (1) | CO6541630A2 (enExample) |
| EC (1) | ECSP12012132A (enExample) |
| GB (1) | GB0921805D0 (enExample) |
| IL (1) | IL220383A (enExample) |
| MX (1) | MX343222B (enExample) |
| NZ (1) | NZ600243A (enExample) |
| PE (1) | PE20121537A1 (enExample) |
| PH (1) | PH12012501203A1 (enExample) |
| RU (1) | RU2564904C2 (enExample) |
| SG (2) | SG10201408377QA (enExample) |
| UA (1) | UA105944C2 (enExample) |
| WO (1) | WO2011073646A1 (enExample) |
| ZA (1) | ZA201204293B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
| US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2170488A1 (en) * | 1993-09-07 | 1995-03-16 | Sekhar Mitra | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| HUP9700654A2 (hu) | 1997-03-26 | 1999-09-28 | Dezső Korbonits | Teobromin tartalmú köhögéscsillapító készítmények |
| US6417206B1 (en) * | 2001-01-26 | 2002-07-09 | Medpointe Healthcare Inc. | Antitussive/antihist aminic/decongestant compositions |
| JP2002308761A (ja) * | 2001-04-09 | 2002-10-23 | Taisho Pharmaceut Co Ltd | 風邪用咳止め薬 |
| JP2003128549A (ja) * | 2001-08-15 | 2003-05-08 | Rohto Pharmaceut Co Ltd | 粘膜適用組成物 |
| JP4377564B2 (ja) * | 2002-05-02 | 2009-12-02 | ロート製薬株式会社 | 内服用組成物 |
| RU2311919C2 (ru) * | 2002-12-30 | 2007-12-10 | Каунсел Оф Сайнтифик Энд Индастриал Рисерч | Разработка противокашлевой и смягчающей горло травяной композиции |
| US20040202677A1 (en) * | 2003-04-10 | 2004-10-14 | Hopkins Kevin J. | Method of enhanced regional body fat reduction |
| US20060153926A1 (en) * | 2005-01-10 | 2006-07-13 | Bascom Charles C | Compositions, products and methods for controlling weight in a mammal |
| US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
| CN100518775C (zh) * | 2007-03-16 | 2009-07-29 | 邓丽菊 | 一种治疗咳喘的药物组合物及其制剂 |
-
2009
- 2009-12-14 GB GBGB0921805.8A patent/GB0921805D0/en not_active Ceased
-
2010
- 2010-12-14 SG SG10201408377QA patent/SG10201408377QA/en unknown
- 2010-12-14 CN CN2010800570306A patent/CN102740843A/zh active Pending
- 2010-12-14 UA UAA201208706A patent/UA105944C2/uk unknown
- 2010-12-14 AU AU2010332494A patent/AU2010332494B2/en not_active Ceased
- 2010-12-14 CA CA2784214A patent/CA2784214C/en not_active Expired - Fee Related
- 2010-12-14 PH PH1/2012/501203A patent/PH12012501203A1/en unknown
- 2010-12-14 SG SG2012043642A patent/SG181686A1/en unknown
- 2010-12-14 EP EP10795446A patent/EP2512464A1/en not_active Ceased
- 2010-12-14 BR BR112012014161A patent/BR112012014161A2/pt not_active IP Right Cessation
- 2010-12-14 JP JP2012543902A patent/JP2013513651A/ja active Pending
- 2010-12-14 RU RU2012129839/15A patent/RU2564904C2/ru not_active IP Right Cessation
- 2010-12-14 PE PE2012000813A patent/PE20121537A1/es not_active Application Discontinuation
- 2010-12-14 CN CN201610214436.XA patent/CN105816462A/zh active Pending
- 2010-12-14 WO PCT/GB2010/052085 patent/WO2011073646A1/en not_active Ceased
- 2010-12-14 NZ NZ600243A patent/NZ600243A/xx not_active IP Right Cessation
- 2010-12-14 MX MX2012006625A patent/MX343222B/es active IP Right Grant
-
2012
- 2012-06-12 ZA ZA2012/04293A patent/ZA201204293B/en unknown
- 2012-06-12 EC ECSP12012132 patent/ECSP12012132A/es unknown
- 2012-06-12 CO CO12098537A patent/CO6541630A2/es unknown
- 2012-06-13 IL IL220383A patent/IL220383A/en not_active IP Right Cessation
-
2015
- 2015-09-28 JP JP2015189231A patent/JP2016040279A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG10201408377QA (en) | 2015-02-27 |
| UA105944C2 (uk) | 2014-07-10 |
| PE20121537A1 (es) | 2012-12-21 |
| IL220383A0 (en) | 2012-08-30 |
| ZA201204293B (en) | 2013-02-27 |
| SG181686A1 (en) | 2012-07-30 |
| ECSP12012132A (es) | 2012-09-28 |
| JP2013513651A (ja) | 2013-04-22 |
| PH12012501203A1 (en) | 2012-11-05 |
| RU2564904C2 (ru) | 2015-10-10 |
| MX343222B (es) | 2016-10-28 |
| BR112012014161A2 (pt) | 2016-05-17 |
| RU2012129839A (ru) | 2014-01-27 |
| CA2784214C (en) | 2018-01-09 |
| CN102740843A (zh) | 2012-10-17 |
| IL220383A (en) | 2017-01-31 |
| EP2512464A1 (en) | 2012-10-24 |
| AU2010332494B2 (en) | 2015-01-15 |
| WO2011073646A1 (en) | 2011-06-23 |
| MX2012006625A (es) | 2012-10-05 |
| CA2784214A1 (en) | 2011-06-23 |
| CO6541630A2 (es) | 2012-10-16 |
| GB0921805D0 (en) | 2010-01-27 |
| CN105816462A (zh) | 2016-08-03 |
| AU2010332494A1 (en) | 2012-06-14 |
| JP2016040279A (ja) | 2016-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009152189A8 (en) | Low dose topiramate/phentermine compostion and methods of use thereof | |
| AR124500A2 (es) | Aumento de la biodisponibilidad de droga en terapia naltrexona | |
| WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
| NZ605888A (en) | Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain | |
| NZ713202A (en) | Diagnosis and treatments relating to th2 inhibition | |
| WO2008131057A3 (en) | Sustained release formulations of opioid and nonopioid analgesics | |
| MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
| NZ589445A (en) | Rasagiline for parkinson's disease modification | |
| AR065392A1 (es) | Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio | |
| WO2012007159A3 (en) | Novel gastro-retentive dosage forms | |
| AR124497A2 (es) | Métodos para tratar los atracones o la ingesta compulsiva de alimentos; uso de buproprion y naltrexona para preparar un medicamento para dichos métodos, y composición farmacéutica | |
| MX344303B (es) | Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor. | |
| ITBO20110012A1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| NZ594067A (en) | VISFATIN THERAPEUTIC AGENTS (PEPTIDES, siRNA, FK-866, APO866 ) FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS | |
| NZ600243A (en) | Combination of theobromine with a decongestant and its use for the treatment of cough | |
| WO2011047837A3 (de) | Schmelzgranuliertes cinacalcet | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
| WO2009019693A3 (en) | Analgesic effect of jasmonate derivatives | |
| NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
| MX2008015323A (es) | Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion. | |
| PH12013501896A1 (en) | Use of a sprayable composition comprising ambroxol | |
| GB201100804D0 (en) | Drug combination | |
| MD3422G2 (ro) | Procedeu de profilaxie şi tratament al knemidocoptozei galinaceelor | |
| GR1008614B (el) | 3,3-διαφαινυλ-ν-(φαινυλαιθυλ)προπαν-1-αμινη: ως νεος και επιλεκτικος προσδετης των σιγμα-1 υποδοχεων, με αντι-απο πτωτικες (κυτταρο-προστατευτικες) ιδιοτητες και με πρωτοτυπη αντικαρκινικη δραση | |
| UA33293U (ru) | Способ лечения хронического эндометрита |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2015 BY OLCOTT Effective date: 20141012 |
|
| ASS | Change of ownership |
Owner name: INFIRST HEALTHCARE LIMITED, GB Effective date: 20141106 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2016 BY OLCOTT Effective date: 20151128 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2017 BY OLCOTT INTERANTIONAL Effective date: 20161205 |
|
| LAPS | Patent lapsed |